<DOC>
	<DOCNO>NCT00701389</DOCNO>
	<brief_summary>Study understand effect migraine treatment blood pressure participant migraine . The primary hypothesis effect semi-recumbent mean arterial pressure follow coadministration telcagepant sumatriptan similar follow administration sumatriptan alone . That , true mean treatment difference ( sumatriptan telcagepant sumatriptan alone ) time-weighted mean arterial pressure 2.5 hour follow dose less 5 mmHg .</brief_summary>
	<brief_title>Study Evaluate Safety , Tolerability , Blood Pressure Effect Oral Dose Sumatriptan Alone Combination With MK-0974 ( Telcagepant ) Migraine Patients ( 0974-026 )</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>History migraine longer 6 month . Free migraine 24 hour dose . Judged good health . Nonsmoker Under age legal consent . Legally mentally incapacitate significant emotional problem . Taking medication 2 week first dose study medication . Has surgery donate blood participate another investigation study within 4 week prior screen Currently regular user illicit drug history drug/alcohol abuse within 2 year Consumes 6 caffeinated beverage per day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>